Correspondence 0001493152-23-045232 from Motus GI Holdings, Inc. (MOTS) (CIK 0001686850)
Motus GI Holdings, Inc. (MOTS) (CIK 0001686850)
Date: Dec. 18, 2023 · CIK: 0001686850 · Accession: 0001493152-23-045232
AI Filing Summary & Sentiment
File numbers found in text: 333-275121
Letter
Re: Motus GI Holdings, Inc. (the “Company”)
December 18, 2023
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
F Street, N.E.
Washington, D.C. 20549
Registration Statement on Form S-1 (File No. 333-275121)
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the above-referenced Registration Statement (the “Registration Statement”) be declared effective by the Securities and Exchange Commission at 5:00 p.m., Eastern Time, on December 18, 2023, or as soon as practicable thereafter.
Please call Steven M. Skolnick of Lowenstein Sandler LLP at 973-597-2476 to confirm the effectiveness of the Registration Statement or with any questions.
Very
truly yours,
SONNET
BIOTHERAPEUTICS HOLDINGS, INC.
Show Raw Text
CORRESP
1
filename1.htm
December
18, 2023
VIA
EDGAR
United
States Securities and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
D.C. 20549
Re:
Motus
GI Holdings, Inc. (the “Company”)
Registration
Statement on Form S-1 (File No. 333-275121)
Ladies
and Gentlemen:
In
accordance with Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the above-referenced Registration
Statement (the “Registration Statement”) be declared effective by the Securities and Exchange Commission at 5:00 p.m., Eastern
Time, on December 18, 2023, or as soon as practicable thereafter.
Please
call Steven M. Skolnick of Lowenstein Sandler LLP at 973-597-2476 to confirm the effectiveness of the Registration Statement or with
any questions.
Very
truly yours,
SONNET
BIOTHERAPEUTICS HOLDINGS, INC.
By:
/s/
Mark Pomeranz
Name:
Mark
Pomeranz
Title:
Chief
Executive Officer